Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells
Monika Fritzer‐Szekeres(Vienna General Hospital), Thomas Szekeres(Medical University of Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Michael Grusch(Comprehensive Cancer Center Vienna), Alexandra Salamon(University of Vienna), Richard Steinbrugger(University of Vienna), Thomas Höchtl(University of Vienna), Walter Jäger, Howard L. Elford(Molecules for Health (United States)), Georg Krupitza(Medical University of Vienna)
Cited by 23
Related Papers
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303